A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia® — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia® — Stella

Home/Postmenopausal Women With Osteoporosis at High Risk of Fracture/

View on ClinicalTrials.gov

Recruiting

Back to Postmenopausal Women With Osteoporosis at High Risk of Fracture trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Zhejiang Provincial People's Hospital Bijie Hospital, Guizhou

Key details

Phase

Large-scale testing

Sponsor

Qilu Pharmaceutical Co., Ltd.

Enrollment target

~278 participants

Started

June 2025

Primary completion

January 2027

Age range

50 Years – 85 Years

Sex

Female only

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.